In a genetically engineered mouse model disseminating pancreatic cancer cells are enriched for CD44+CD24+ CSC compared to the primary PanIN lesion or tumor, and have increased proliferation rates and spheroid formation capacity in vitro [9]. The gene discussed is CD44; the disease is familial pancreatic carcinoma.